Efficacy of different doses of sugammadex after continuous infusion of rocuronium

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Clin Cases. Apr 16, 2015; 3(4): 360-367
Published online Apr 16, 2015. doi: 10.12998/wjcc.v3.i4.360

Table 3 Adverse events

Adverse events	Group A	Group B
Arterial hypertension	0%	0%
Arterial hypotension	0%	0%
Bradycardia	0%	0%
Cough	0%	0%
Headache	0%	0%
Nausea	6.20%	6.20%
Pain	6.20%	6.20%
Residual neuromuscular blocking	0%	0%
Vomiting	0%	0%
Others	0%	6.20%

Citation: Mesa DS, Fayad MF, Arviza LP, Ruiz VDV, Carreño FC, Tamargo LA, Díaz MA, Montes SFP. Efficacy of different doses of sugammadex after continuous infusion of rocuronium. World J Clin Cases 2015; 3(4): 360-367
URL: https://www.wjgnet.com/2307-8960/full/v3/i4/360.htm
DOI: https://dx.doi.org/10.12998/wjcc.v3.i4.360

Mesa DS, Fayad MF, Arviza LP, Ruiz VDV, Carreño FC, Tamargo LA, Díaz MA, Montes SFP. Efficacy of different doses of sugammadex after continuous infusion of rocuronium. World J Clin Cases 2015; 3(4): 360-367 [PMID: 25879008 DOI: 10.12998/wjcc.v3.i4.360]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.